Pregnancy-Related Changes of Amino Acid and Acylcarnitine Concentrations: The Impact of Obesity.
Objective Our primary objective was to assess the difference in amino and fatty acid biomarkers throughout pregnancy in women with and without obesity. Interactions between biomarkers and obesity status for associations with maternal and fetal metabolic measures were secondarily analyzed. Methods Overall 39 women (15 cases, 24 controls) were enrolled in this study during their 15- to 20-weeks' visit at the University of Iowa Hospitals and Clinics. We analyzed 32 amino acid and acylcarnitine concentrations with tandem mass spectrometry for differences throughout pregnancy as well as among women with and without obesity (body mass index [BMI] ≥ 35, BMI < 25). Results There were substantial changes in amino acids and acylcarnitine metabolites between the second and third trimesters (nonfasting state) of pregnancy that were significant after correcting for multiple testing (p < 0.002). Examining differences by maternal obesity, C8:1 (second trimester) and C2, C4-OH, C18:1 (third trimester) were higher in women with obesity compared with women without obesity. Several metabolites were marginally (0.002 < p < 0.05) correlated with birth weight, maternal glucose, and maternal weight gain stratified by obesity status and trimester. Conclusions Understanding maternal metabolism throughout pregnancy and the influence of obesity is a critical step in identifying potential mechanisms that may contribute to adverse outcomes in pregnancies complicated by obesity.
Department of Epidemiology, University of Iowa, Iowa City, Iowa.
Kelli K
KK
Ryckman
Department of Epidemiology, University of Iowa, Iowa City, Iowa.
Brittney M
BM
Donovan
Department of Obstetrics and Gynecology, University of Iowa, Iowa City, Iowa.
Diedre K
DK
Fleener
Department of Pediatrics, University of Iowa, Iowa City, Iowa.
Bruce
B
Bedell
Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota.
Kristi S
KS
Borowski
acylcarnitines; amino acids; fatty acids; longitudinal; maternal obesity; pregnancy
J Nutr. 2006 Jun;136(6 Suppl):1731S-1740S
16702348
Metabolism. 1977 Feb;26(2):151-6
834148
Eur J Epidemiol. 2015 Nov;30(11):1175-85
26666541
Cell Metab. 2009 Apr;9(4):311-26
19356713
Am J Obstet Gynecol. 1995 May;172(5):1605-14
7755079
Epigenetics. 2011 Jan;6(1):86-94
20864804
J Proteome Res. 2011 Oct 7;10(10):4769-88
21823675
Am J Clin Nutr. 2000 Jan;71(1 Suppl):285S-91S
10617984
Gynecol Endocrinol. 2006 Jun;22(6):343-9
16785160
Hum Reprod Update. 2010 May-Jun;16(3):255-75
19966268
J Nutr. 2001 May;131(5):1631S-6S
11340130
J Nutr Biochem. 2012 Feb;23(2):133-9
21429726
Nature. 2006 Dec 14;444(7121):875-80
17167476
Clin Chem. 2004 Aug;50(8):1406-12
15166109
Metabolomics. 2012 Aug;8(4):556-565
25067934
Public Health Nutr. 2013 Aug;16(8):1414-8
23522785
Mol Cells. 2015 Jul;38(7):587-96
26072981
Semin Fetal Neonatal Med. 2009 Apr;14(2):66-71
18986856
Clin Biochem. 2013 Jan;46(1-2):133-8
23010448
Mol Biosyst. 2006 Mar;2(3-4):174-83
16880935
J Pregnancy. 2014;2014:123024
24883207
Altern Med Rev. 2003 Feb;8(1):7-19
12611557